Real-time enrollment status for this prostate cancer clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:11 AM UTC
| NCT Number | NCT06800313 |
| Recruiting Status | Recruiting |
| Condition | Prostate Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 33 participants |
| Active Locations | 6 sites in the US |
| Sponsor | Halda Therapeutics OpCo, Inc. |
| Last Updated on CT.gov | October 16, 2025 (Oct 16, 2025) |
As of March 2, 2026: Clinical trial NCT06800313 is currently recruiting participants. This clinical trial study for prostate cancer is actively seeking new participants at 6 locations across the United States. The study is sponsored by Halda Therapeutics OpCo, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06800313 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06800313 was last updated Oct 16, 2025 (October 16, 2025). HelloStudys verifies this status automatically.